EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characteristics and Correlates of Illness Severity in a Clozapine-Treated Cohort: A Service Evaluation From Suffolk

Nada Zahreddine, Lucy Mountford, Sarah Zahreddine, Ahmed Ibrahim, Angelos Zikos, Mohamed Elkoshiery, Maria Giner-Murillo

BJPsych Open · 2026-06 · 12 (S1) · S250-S250

DOI: 10.1192/bjo.2026.11617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 30.06.2026. Verfasst von Nada Zahreddine und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Clozapine is the gold-standard treatment for treatment-resistant schizophrenia. Its requirement for regular blood testing and monitoring has led to centralised clozapine clinics in the UK, yet real-world data remain limited.

Methods

This cross-sectional service evaluation examined patients attending a clozapine clinic serving adult secondary care services across Suffolk. Demographic, clinical, and service-provision data were extracted from electronic health records. Illness severity was assessed using the Clinical Global Impression–Schizophrenia scale (CGI-SCH), and functioning using the Global Assessment of Functioning (GAF).

Results

The cohort comprised 257 patients (mean age 46.9 years, SD=12.4), predominantly male (68.9%) and largely White British (78.0%); 35.2% were current smokers. Meanclozapine dose was 330.4 mg/day (SD=134.0), with a mean treatment duration of 12.4 years (SD=7.8). In the prior year, 81.7% attended the clinic, 48.2% had at least one clozapine plasma level recorded, 12.1% had an inpatient admission, 32.7% had an allocated care coordinator, and patients attended a mean of 2.7 psychiatrist appointments (SD=1.3). In addition to clozapine, 26.5% were prescribed an additional antipsychotic (most commonly aripiprazole 14.8% and amisulpride 11.7%). The most frequently prescribed mood stabilisers were valproate (11.7%) and lithium (3.9%). Antidepressants were prescribed in 44.4%, and benzodiazepines in 17.9%. The most prevalent primary diagnoses were schizophrenia (86.4%) and schizoaffective disorder (10.1%). Common psychiatric comorbidities included autism spectrum disorder/learning disability (ASD/LD; 14.8%), anxiety disorders (12.5%), obsessive–compulsive disorder (5.4%), and major depressive disorder (MDD; 4.3%). Mean CGI-SCH scores indicated low overall symptom severity (CGI-Severity M=2.28, SD=1.17). Mean GAF score was 61.1 (SD=14.6), consistent with mild–moderate functional impairment. Symptomatic remission (CGI ≤ 3) was observed in 85.4%, and functional remission (CGI ≤ 3 and GAF ≥ 60) in 55.5%. Male gender was associated with greater negative symptom severity (p=.045), while female gender was associated with greater depressive symptom severity (p=.045) and antidepressant prescribing (p=.004). Multivariable linear regression predicting CGI-Severity was statistically significant (p < .001). After adjustment for demographic, clinical, and treatment-related variables, higher illness severity was independently associated with schizoaffective disorder, MDD, ASD/LD, higher clozapine dose, shorter clozapine treatment duration, recent inpatient admission, and recent changes to clozapine dosing (all p ≤ .030).

Conclusion

Clozapine-treated patients showed high rates of symptomatic remission, yet illness severity was independently associated with diagnostic complexity and markers of clinical instability, highlighting targets for enhanced, proactive service input.

Zitieren

APA

Zahreddine, N., Mountford, L., Zahreddine, S., Ibrahim, A., Zikos, A., Elkoshiery, M., & Giner-Murillo, M. (2026). Clinical Characteristics and Correlates of Illness Severity in a Clozapine-Treated Cohort: A Service Evaluation From Suffolk. BJPsych Open, 12(S1), S250-S250. https://doi.org/10.1192/bjo.2026.11617

Vancouver

Zahreddine N, Mountford L, Zahreddine S, Ibrahim A, Zikos A, Elkoshiery M, et al. Clinical Characteristics and Correlates of Illness Severity in a Clozapine-Treated Cohort: A Service Evaluation From Suffolk. BJPsych Open. 2026;12(S1):S250-S250. doi:10.1192/bjo.2026.11617

BibTeX
@article{Zahreddine2026,
  author = {Zahreddine, Nada and Mountford, Lucy and Zahreddine, Sarah and Ibrahim, Ahmed and Zikos, Angelos and Elkoshiery, Mohamed and Giner-Murillo, Maria},
  title = {Clinical Characteristics and Correlates of Illness Severity in a Clozapine-Treated Cohort: A Service Evaluation From Suffolk},
  journal = {BJPsych Open},
  year = {2026},
  volume = {12},
  number = {S1},
  pages = {S250--S250},
  doi = {10.1192/bjo.2026.11617}
}
Kostenlos starten →